Selectivity Profiling and Biological Activity of Novel β-Carbolines as Potent and Selective DYRK1 Kinase Inhibitors.
DYRK1A is a pleiotropic protein kinase with diverse functions in cellular regulation, including cell cycle control, neuronal differentiation, and synaptic transmission. Enhanced activity and overexpression of DYRK1A have been linked to altered brain development and function in Down syndrome and neur...
Main Authors: | Katharina Rüben, Anne Wurzlbauer, Agnes Walte, Wolfgang Sippl, Franz Bracher, Walter Becker |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2015-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC4508061?pdf=render |
Similar Items
-
How to Separate Kinase Inhibition from Undesired Monoamine Oxidase A Inhibition—The Development of the DYRK1A Inhibitor AnnH75 from the Alkaloid Harmine
by: Anne Wurzlbauer, et al.
Published: (2020-12-01) -
Neue Kinaseinhibitoren vom β- und γ-Carbolin-Typ
by: Wurzlbauer, Anne
Published: (2013) -
Mutational analysis of two residues in the DYRK homology box of the protein kinase DYRK1A
by: Esti Wahyu Widowati, et al.
Published: (2018-05-01) -
DYRK1A Kinase Inhibitors Promote β-Cell Survival and Insulin Homeostasis
by: Agata Barzowska, et al.
Published: (2021-08-01) -
β-carboline compounds, including harmine, inhibit DYRK1A and tau phosphorylation at multiple Alzheimer's disease-related sites.
by: Danielle Frost, et al.
Published: (2011-05-01)